<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CerMed Corporation</title>
	<atom:link href="http://cermedcorp.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://cermedcorp.com</link>
	<description>Innovative Diagnostics for a Healthier World</description>
	<lastBuildDate>Thu, 09 May 2013 15:07:27 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>CerMed Makes Key Executive Appointments &#8211; Cervical Cancer/HPV Test Moves Closer To Commercial Launch</title>
		<link>http://cermedcorp.com/cermed-makes-key-executive-appointments-cervical-cancerhpv-test-moves-closer-to-commercial-launch/</link>
		<comments>http://cermedcorp.com/cermed-makes-key-executive-appointments-cervical-cancerhpv-test-moves-closer-to-commercial-launch/#comments</comments>
		<pubDate>Fri, 23 Mar 2012 05:15:07 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=347</guid>
		<description><![CDATA[MONTEREY, CA – CerMed Corporation, a privately held company, announced today that it has recruited two key executives to help complete development and commercialization of the company’s emerging line of cancer test and prevention products. The new appointments are expected to accelerate launch of the company’s cervical cancer/HPV screening test and its woman&#8217;s-choice, combination contraceptive [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-makes-key-executive-appointments-cervical-cancerhpv-test-moves-closer-to-commercial-launch/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International announces share exchange</title>
		<link>http://cermedcorp.com/cermed-international-announces-share-exchange/</link>
		<comments>http://cermedcorp.com/cermed-international-announces-share-exchange/#comments</comments>
		<pubDate>Tue, 06 Mar 2012 05:13:31 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=344</guid>
		<description><![CDATA[Monterey, CA – CerMed International, Inc. (CRX), a Canadian corporation (the “Company”), announces that its board and shareholders recently approved a share exchange transaction with its Delaware subsidiary (“CerMed Delaware”), such that Company shareholders who participate in the exchange will become holders of CerMed Delaware shares and will no longer be holders of Company shares. [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-announces-share-exchange/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International Announces the Commencement of the CerCap Clinical Trial</title>
		<link>http://cermedcorp.com/cermed-international-announces-the-commencement-of-the-cercap-clinical-trial/</link>
		<comments>http://cermedcorp.com/cermed-international-announces-the-commencement-of-the-cercap-clinical-trial/#comments</comments>
		<pubDate>Wed, 14 Dec 2011 05:13:01 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=342</guid>
		<description><![CDATA[Monterey, CA – CerMed International (Frankfurt Stock Exchange: CRX), an international women’s medical device company, announced today that an initial clinical trial for its CerCap device, a multipurpose, drug-eluting cervical barrier cap that provides the dual benefits of contraception and a reduction of the risk of infection with HIV, will begin January 2012 in Zimbabwe. [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-announces-the-commencement-of-the-cercap-clinical-trial/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International announces CE Mark for its CerMap product</title>
		<link>http://cermedcorp.com/cermed-international-announces-ce-mark-for-its-cermap-product/</link>
		<comments>http://cermedcorp.com/cermed-international-announces-ce-mark-for-its-cermap-product/#comments</comments>
		<pubDate>Fri, 18 Nov 2011 05:10:13 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=337</guid>
		<description><![CDATA[Monterey, CA – CerMed International (Frankfurt Stock Exchange: CRX), an international women’s medical device company, announced today that it has received CE Mark registration for CerMap its advanced Cervical Specimen Collection Device used in cervical cancer screening (Pap) procedures. After a review of the CerMap Technical File by Emergo Europe, CerMed’s Authorized Representative, the Company [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-announces-ce-mark-for-its-cermap-product/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International announces Irene Podolak joins the Board of Directors</title>
		<link>http://cermedcorp.com/cermed-international-announces-irene-podolak-joins-the-board-of-directors/</link>
		<comments>http://cermedcorp.com/cermed-international-announces-irene-podolak-joins-the-board-of-directors/#comments</comments>
		<pubDate>Wed, 31 Aug 2011 05:06:18 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=331</guid>
		<description><![CDATA[Monterey, CA – CerMed International (Frankfurt Stock Exchange: CRX), an international medical device company with several breakthrough products addressing global women’s health issues, announced today that Irene Podolak has joined their Board of Directors. Ms. Podolak has over 30 years of very broad experience in the health industry including positions in community based hospitals, large [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-announces-irene-podolak-joins-the-board-of-directors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International announces trading of new shares</title>
		<link>http://cermedcorp.com/cermed-international-announces-trading-of-new-shares/</link>
		<comments>http://cermedcorp.com/cermed-international-announces-trading-of-new-shares/#comments</comments>
		<pubDate>Tue, 30 Aug 2011 05:05:19 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=329</guid>
		<description><![CDATA[Monterey, CA – CerMed International (Frankfurt Stock Exchange: CRX), an international medical device company with several breakthrough products addressing global women’s health issues, announces that trading has resumed with new shares under their new trading symbol “CRX” on the Frankfurt Stock Exchange. Here is the Share information: CUSIP #: 15677A206 ISIN#: CA 15677A2065 WKN#: A1JHQT [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-announces-trading-of-new-shares/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International to present at Small Cap Conference in Frankfurt on August 29th</title>
		<link>http://cermedcorp.com/cermed-international-to-present-at-small-cap-conference-in-frankfurt-on-august-29th/</link>
		<comments>http://cermedcorp.com/cermed-international-to-present-at-small-cap-conference-in-frankfurt-on-august-29th/#comments</comments>
		<pubDate>Fri, 26 Aug 2011 05:04:36 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=327</guid>
		<description><![CDATA[Monterey, CA – CerMed International (Listed on the Frankfurt Stock Exchange), an international medical device company with several breakthrough products addressing global women’s health issues, today announced that the company will present at the Small Cap Conference in Frankfurt: Date: Monday, August 29th 2011 Time: 4:45 – 5:25 p.m. CET Presenter: Peter Gombrich, CEO CerMed [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-to-present-at-small-cap-conference-in-frankfurt-on-august-29th/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International announces a Shareholder Decision</title>
		<link>http://cermedcorp.com/cermed-international-announces-a-shareholder-decision/</link>
		<comments>http://cermedcorp.com/cermed-international-announces-a-shareholder-decision/#comments</comments>
		<pubDate>Thu, 28 Jul 2011 05:03:35 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=325</guid>
		<description><![CDATA[Monterey, CA – CerMed International, a women’s healthcare medical device company, recently determined that a reverse stock split was necessary to accelerate the cancelation of shares granted as part of a March 2011 voided contract. The cancelled shares, in the form of stock certificates and electronic issuance format, will no longer be tradable in the [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-announces-a-shareholder-decision/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International announces a Board of Directors’ Action</title>
		<link>http://cermedcorp.com/cermed-international-announces-a-board-of-directors-action/</link>
		<comments>http://cermedcorp.com/cermed-international-announces-a-board-of-directors-action/#comments</comments>
		<pubDate>Wed, 20 Jul 2011 05:02:42 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=323</guid>
		<description><![CDATA[Monterey, CA – CerMed International, a women’s healthcare medical device company, today announced a decision of the Board of Directors to resolve an electronic shares situation that is negatively impacting the Company’s share price. A portion of cancelled shares that are in electronic format are still being sold into the market even though they have [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-announces-a-board-of-directors-action/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CerMed International Gives an Update</title>
		<link>http://cermedcorp.com/cermed-international-gives-an-update/</link>
		<comments>http://cermedcorp.com/cermed-international-gives-an-update/#comments</comments>
		<pubDate>Fri, 08 Jul 2011 05:01:25 +0000</pubDate>
		<dc:creator>JKNetDesign</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://cermedcorp.com/?p=321</guid>
		<description><![CDATA[FOR IMMEDIATE RELEASE CONTACT CerMed International (831) 920 2275 (o) info@cermedint.com www.cermedint.com CerMed International Gives an Update Monterey, CA – CerMed International, a women’s healthcare medical device company, announced the following update on its activities to its shareholders. Peter Gombrich, CEO &#38; Chairman said, “We are very pleased to report on the progress that CerMed [...]]]></description>
		<wfw:commentRss>http://cermedcorp.com/cermed-international-gives-an-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
